The Point of Care Joint Venture Program is revolutionizing the way large practices increase monthly revenue
Many practices are still using offsite laboratories to process their patients Respiratory and Urinary Tract related cultures. Often these facilities are not only billing the insurance carrier, they also send patients to collections.
The Integration of this system will grant you billing privileges and the control of your patient’s financial outcome.
Testing Benefits
Rapid same day test results
Test your patients in-office and get test results during the same visit.
Determine if your patient needs antibiotics.
Antibiotic resistance read out
Test results will provide the antibiotic resistance of the organism that presents as positive in your patients test results. Stop using antibiotics that don’t cure your patient.
Test your patients on a clinical level just like the Laboratories.
By integrating the point of care system into your office. Your medical practice will elevate with robust services, increased treatment capabilities and monthly revenue.
The Joint Venture program is a complete turnkey opportunity
We have designed this program to be effortless on your part. We provide • The setup (including your C.L.I.A license) • The device • The technician • The supplies • The Billing
Compliant with the Antibiotic stewardship program
The CDC has started to mandate the use of antibiotic alternatives for long-term managed care. By reducing the use of antibiotics patients will have less resistance when it is truly needed. We have created a program that keeps you compliant with monthly reports. PCR testing will help reduce the use of antibiotics and increase your facility health score. It is only a matter of time before it is mandated at the clinical level.
Why use PCR Technology
CDC Guideline on Rapid influenza test kits (RIDTs) “If an important clinical decision is affected by the test result, the RIDTs result should be confirmed by a molecular assay, such as reverse transcription polymerase chain reaction (RTPCR)” 96% more accurate than traditional culture testing. The test is unaffected by the use of antibiotics
What is Respiratory Panel Testing?
RPP is a qualitative test that will identify DNA from respiratory viruses and bacteria extracted from nasopharyngeal swabs from individuals with clinical signs and symptoms of a respiratory tract infection. This panel employs PCR (polymerase chain reaction) technology which is used to “amplify” small quantities of nucleic acid into detectable levels which leads to accurate results.
What Is Urinary Tract Infection Testing?
UTI (urinary tract infection) testing utilizes quantitative Polymerase Chain Reaction (PCR) to rapidly analyze your patient’s sample. PCR technology precisely detects the correct pathogen(s) and identifies antibiotic drug resistance. This allows providers the ability to prescribe timely and effective treatment
What does this mean for your practice?
This test will prove if a patient has a virus and does not require antibiotics, thereby affirming a provider’s decision to avoid drugs that are unnecessary and can have significant side effects.
100% Increased Clinical Value
0% Over prescription of Antibiotics
45 Minutes- Timely actionable results
Immediately - Stop guesing and start treating
$0.00 - No up front costs
Just 8-10 tests a day can generate over $25K+ per month in net revenue
How does Joint Venture Work?
All the following is provided at Zero Cost
Custom Insurance Proforam evaluation
C.L.I.A WAIVED LICENSE
Dedicated onsite technician
Point of care tesing device
All-inclusive Billing
Copyright © 2018 Dnahealthservices - All Rights Reserved.